PAL 0.00% 29.5¢ palla pharma limited

Ann: Palla 1H2019 Results Investor Presentation, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,403 Posts.
    lightbulb Created with Sketch. 266

    Gross profit increased by 23,7 %
    Net debt increased 36,2%.
    Net finance expenses increase from 966 000 to 1 588 000 - 64%.

    "Net debt increased by $7.6m during theperiod to fund additional inventories andfinance expenses. 28,6 mln debt at the moment.
    Net finance expenses were unfavourablyimpacted by higher working capital debtfacility utilisation for the period driven byincreased working capital employed ininventories due to the high codeine patentlitigation-1,6 mln."
    Gross profit increases at slower pace compared with all the expenses and debt payments.

    IMO share price reflects all given above.


 
watchlist Created with Sketch. Add PAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.